Immunotherapies for Life

SC 13G

SEC Filing Details

Document Details

Filing Date
Nov 7, 2018
Document Date
Nov 7, 2018
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
3,4,5
Company
Y-mAbs Therapeutics, Inc.
Issuer
Y-mAbs Therapeutics, Inc.